Drug overdose deaths continue to increase in the United States.
From 1999 to 2017, more than 700,000 people have died from a drug overdose.Around 68% of the more than 70,200 drug overdose deaths in 2017 involved an opioid.In 2017, the number of overdose deaths involving opioids (including prescription opioids and illegal opioids like heroin and illicitly manufactured fentanyl) was 6 times higher than in 1999.On average, 130 Americans die every day from an opioid overdose.1
The Three Waves of Opioid Overdose Deaths
From 1999-2017, almost 400,000 people died from an overdose involving any opioid, including prescription and illicit opioids.2
This rise in opioid overdose deaths can be outlined in three distinct waves.
The first wave began with increased prescribing of opioids in the 1990s 3, with overdose deaths involving prescription opioids (natural and semi-synthetic opioids and methadone) increasing since at least 1999.The second wave began in 2010, with rapid increases in overdose deaths involving heroin.The third wave began in 2013, with significant increases in overdose deaths involving synthetic opioids – particularly those involving illicitly-manufactured fentanyl (IMF). The IMF market continues to change, and IMF can be found in combination with heroin, counterfeit pills, and cocaine. 2,4
Combatting the Opioid Overdose Epidemic
CDC is committed to fighting the opioid overdose epidemic and supporting states and communities as they continue work to identify outbreaks, collect data, and respond to overdoses, and provide care to those in their communities.
CDC’s Prevention for States and Data-Driven Prevention Initiative programmatic aims center around the enhancement of PDMPs within clinical and public health settings, insurer and community interventions, evaluation of state-level policies, and other innovative strategies that states can employ. CDC’s Enhanced State Opioid Overdose Surveillance program aims to support and build the capacity of states to monitor the epidemic by improving the timeliness and quality of surveillance data focusing on both fatal and nonfatal opioid overdose.
CDC’s work focuses on:
Building prevention efforts by equipping states with resources, improving data collection, and supporting the use of evidence-based prevention strategies.Improving data quality and tracking trends to better understand and respond to the epidemic. Collecting and analyzing data on opioid-related overdoses to better identify areas that need assistance and to evaluate prevention efforts.Supporting healthcare providers and health systems with data, tools, and guidance for evidence-based decision-making to improve opioid prescribing and patient safety.Partnering with public safety officials, including law enforcement, to address the growing illicit opioid problem.Encouraging consumers to make safe choices about opioids and raising awareness about prescription opioid misuse and overdose.
Collaboration is essential for success in prevention opioid overdose deaths. Medical personnel, emergency departments, first responders, public safety officials, mental health and substance abuse treatment providers, community-based organizations, public health, and members of the community all bring awareness, resources, and expertise to address this complex and fast-moving epidemic. Together, we can better coordinate efforts to prevent opioid overdoses and deaths.
CURATED SOURCE: CDC
References
Wide-ranging online data for epidemiologic research (WONDER). Atlanta, GA: CDC, National Center for Health Statistics; 2017. Available at http://wonder.cdc.gov.Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and Opioid-Involved Overdose Deaths – United States, 2013-2017. WR Morb Mortal Wkly Rep. ePub: 21 December 2018.Kolodny et al. 2015. The prescription opioid and heroin crisis: A public health approach to an epidemic of addictionexternal icon. Annual Review of Public Health 2015 (36); 559-74.Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in Drug and Opioid Overdose Deaths – United States, 2000-2014. MMWR 2016, 64(50); 1378-82.
Comments